-
Product Insights
Ankylosing Spondylitis (Bekhterev’s Disease) Clinical Trial Analysis by Phase, Trial Status, End Point, Sponsor Type and Region, 2024 Update
Ankylosing Spondylitis Clinical Trial Analysis Report Overview A total of 1,072 Ankylosing Spondylitis clinical trials were conducted as of January 2024. The Ankylosing Spondylitis clinical trial report provides a comprehensive understanding of the Ankylosing Spondylitis clinical trial scenario across regions, and countries (G7 & E7), along with insights into the various phases, trial status, and end points status. The report also includes information about the sponsor type and the prominent sponsors associated with the trials. Key Regions ·       Asia-Pacific ·       ...
-
Product Insights
NewAxial Spondyloarthritis – Drugs In Development, 2024
Empower your strategies with our Axial Spondyloarthritis – Drugs In Development, 2024 report and make more profitable business decisions. Axial spondylitis is a type of inflammatory arthritis involving the spine and/or sacroiliac joints. Axial spondylitis is strongly related to the presence of the HLA-B27 gene. A genetic test for HLA-B27 is available. The Axial Spondyloarthritis drugs in development market research report provide comprehensive information on the therapeutics under development for Axial Spondyloarthritis, complete with analysis by stage of development, drug target,...
-
Product Insights
NewAnkylosing Spondylitis (Bekhterev’s Disease) – Drugs In Development, 2024
Empower your strategies with our Ankylosing Spondylitis (Bekhterev's Disease) – Drugs In Development, 2024 report and make more profitable business decisions. Ankylosing spondylitis is a type of arthritis that affects the spine. Ankylosing spondylitis symptoms include pain and stiffness from the neck down to the lower back. The spine's bones (vertebrae) may grow or fuse together, resulting in a rigid spine. These changes may be mild or severe, and may lead to a stooped-over posture. The Ankylosing Spondylitis (Bekhterev's Disease) drugs...